These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 10856565)
1. Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients: 6-year experience at the Sheba Medical Center. Lavee J; Bar-Zohar D; Har-Zahav Y; Freimark D; Casif Y; Shinfeld A; Smolinsky AK Transplant Proc; 2000 Jun; 32(4):737-9. PubMed ID: 10856565 [No Abstract] [Full Text] [Related]
2. Rabbit antithymocyte globulin induction immunosuppression in heart transplantation. Chien NC; Lin FL; Chou NK; Hsu RB; Wang SS; Chu SH; Ko WJ Transplant Proc; 2000 Nov; 32(7):2380-2. PubMed ID: 11120209 [No Abstract] [Full Text] [Related]
3. Anti-T-cell-antibody prophylaxis in children: success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum. Boucek MM; Pietra B; Sondheimer H; Luna M; Shaffer E; Hall P; Campbell D Transplant Proc; 1997 Dec; 29(8A):16S-20S. PubMed ID: 9414669 [No Abstract] [Full Text] [Related]
11. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients. Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168 [No Abstract] [Full Text] [Related]
12. Influence of rejection on late graft function after heart transplantation. Livi U; Milano A; Caforio AL; Grassi G; Feltrin G; Boffa GM; D'Agnolo A; Angelini A; Thiene G; Casarotto D Transplant Proc; 1994 Oct; 26(5):2727-8. PubMed ID: 7940855 [No Abstract] [Full Text] [Related]
13. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results. Schulz T; Kapischke M; Busing M Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475 [TBL] [Abstract][Full Text] [Related]
14. Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute. Beaufigeau M; Dumesnil D; Carrier M; White M; Pelletier GB Transplant Proc; 1997 Nov; 29(7A):10S-12S. PubMed ID: 9366918 [No Abstract] [Full Text] [Related]
15. Risk factors for early mortality, acute rejection, and factors affecting first-year survival after heart transplantation. Aziz T; el-Gamel A; Krysiak P; Rahman A; Campbell C; Yonan N; Deiraniya A Transplant Proc; 1998 Aug; 30(5):1912-4. PubMed ID: 9723330 [No Abstract] [Full Text] [Related]
16. Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation. Bruce DS; Newell KA; Woodle ES; Millis JM; Piper JB; Huss E; Thistlethwaite JR Transplant Proc; 1996 Aug; 28(4):2136-7. PubMed ID: 8769180 [No Abstract] [Full Text] [Related]
17. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3. Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282 [TBL] [Abstract][Full Text] [Related]
18. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years. MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774 [No Abstract] [Full Text] [Related]